Subscribe to Newsletter

Basic & Translational Research

Subspecialties Retina

The Test of Time

| Michel Michaelides

Reflecting on the past – and future – of gene therapy

Subspecialties Retina

(Not) Going Viral

| Mariya Moosajee

Plasmid vectors are gaining traction as a viable alternative in gene therapy delivery

Subspecialties Basic & Translational Research

Changing the Channel

| Phoebe Harkin

A quest to tackle LCA emphasizes the essence of precision medicine

Subspecialties Basic & Translational Research

From iPSC to RPE to Therapy

| Phoebe Harkin

Will stem-cell success in animals translate to humans?

Subspecialties Basic & Translational Research

Bitesize Breakthroughs

| Phoebe Harkin

The latest ophthalmology news – in brief

Subspecialties Glaucoma

H(eye) – or Low?

| Phoebe Harkin

Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse

Subspecialties Basic & Translational Research

Three (Hundred) Blind Mice

| Phoebe Harkin

Californian researchers discover 261 new genes for hereditary eye disease

Subspecialties Glaucoma

A Glimpse Over the Horizon

| Jeffrey O'Callaghan

The research tackling the pressing and substantial need for new gene medications targeting conventional aqueous outflow

Subspecialties Cataract

The Crystal Maze

| Eugene Serebryany, Phoebe Harkin

Uncovering the complex biochemistry behind cataract formation

Subspecialties Retina

See the Light

| Steve Charles

New advances in regenerative medicine bring hope to patients suffering from blinding disorders of the outer retina.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: